Haisco Pharmaceutical Group Co., Ltd.
002653
Rank in Stocks
#2164
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Share Price
$8.28
Market Cap
$9.44B
Change (1 day)
0.60%
Change (1 year)
12.37%
Country
CN
Trade Haisco Pharmaceutical Group Co., Ltd. (002653)
Category
Healthcare
Operating Margin for Haisco Pharmaceutical Group Co., Ltd. (002653)
Operating Margin as of October 2026 TTM: 13.82%
According to Haisco Pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 13.82%. At the end of 2023 the company had an Operating Margin of 9.35%.
Operating Margin history for Haisco Pharmaceutical Group Co., Ltd. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 13.82% | 1.32% |
| 2024 | 13.64% | 45.88% |
| 2023 | 9.35% | -22.66% |
| 2022 | 12.09% | -34.54% |
| 2021 | 18.47% | -12.01% |
| 2020 | 20.99% | 51.12% |
| 2019 | 13.89% | 46.98% |
| 2018 | 9.45% | -34.05% |
| 2017 | 14.33% | -40.86% |
| 2016 | 24.23% | -27.48% |
| 2015 | 33.41% | -11.00% |
| 2014 | 37.54% | -19.25% |
| 2013 | 46.49% | 6.90% |
| 2012 | 43.49% | -8.52% |
| 2011 | 47.54% | -4.88% |
| 2010 | 49.98% | -10.09% |
| 2009 | 55.59% | -3.81% |
| 2008 | 57.79% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -97.21% |
US
|
|
| -149.01% | -110.78% |
US
|
|
| 25.57% | -98.15% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -97.92% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.